Neuroinflammation Markers are specific biochemical or cellular indicators, measurable in biological fluids or imaging, that signify the presence and activity of an inflammatory response within the central nervous system (CNS). These markers, which include cytokines, chemokines, and activated glial cells, provide clinical evidence of chronic, low-grade brain inflammation. Elevated levels are often associated with neurodegenerative processes and can profoundly disrupt the hypothalamic-pituitary axes, impairing hormonal regulation.
Origin
The concept evolved from the study of systemic inflammation, with the recognition that the brain, previously thought to be immune-privileged, possesses its own resident immune cells (microglia and astrocytes). The identification of specific molecular signatures allowed for the clinical measurement of this localized inflammatory state. This field is now central to psychoneuroendocrinology and longevity research.
Mechanism
When the CNS is exposed to chronic stress, infection, or metabolic dysfunction, resident microglia become activated, releasing pro-inflammatory cytokines such as IL-6 and TNF-alpha. These signaling molecules disrupt the blood-brain barrier and interfere with neurotransmitter and neuropeptide signaling, including those controlling pituitary hormone release. Monitoring these markers provides a direct window into the brain’s inflammatory status and its impact on systemic hormonal health.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.